10
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
panel
FasterCures Roundtable (Invite only)
As health systems worldwide recover and rebuild in the retention wake of COVID-19, the importanc
e of early preparation, multi-stakeholder collaboration, and constant innovation must not be forgotten.
+ Read More
landing page
Achieving Health Equity and Diversity in Clinical Trials
The underrepresentation of diverse groups in clinical research, mistrust in research, and the lack o
f diversity in the health workforce play significant roles in the persistence of health inequities.
+ Read More
landing page
Changemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem?, Members are Guide
d by the Following Statement of Purpose
We are a collective of philanthropic innovators that have come together to:, FasterCures’ Changemakers Members
Jeff Allen, CEO, Friends of Cancer Research
Margaret Anderson, Managing Director, Deloitte (FasterCures Board Liaison)
+ Read More
report
The Current Landscape of the Science of Patient Input
In the last decade, FasterCures and many stakeholders across the biomedical research ecosystem have
driven initiatives to ensure that patients’ perspectives and input are appropriately represented across the product-development continuum and post-approv
+ Read More
panel
UAE Medical Research and Health System Site Visit (Invite only)
A small delegation of leading health experts from the FasterCures board and MENA Summit will tou
r institutions in Abu Dhabi to expand participants' understanding of UAE investments in health and biomedical research.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
video
Advances in Science: Beyond “One Disease at a Time:” Therapeutic Platforms for Monogenic Disease
Guest speaker Philip John (P.J.) Brooks, PhD, acting director of the Division of Rare Diseases Res
earch Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) delivered a presentation about cell an
+ Read More
video
Research Roadmaps: A Case Study in Charting a Path Forward to Accelerate Breakthrough Cures
Setting specific objectives and establishing strategies geared toward progressing treatments and c
ures is a critical, yet sometimes difficult, task for patient organizations.
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically